IVVD Invivyd Inc

Price (delayed)

$4.24

Market cap

$466.89M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.55

Enterprise value

$287.63M

Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has ...

Highlights
The net income has grown by 39% YoY and by 3.2% from the previous quarter
The quick ratio has grown by 9% YoY and by 8% from the previous quarter
Invivyd's debt has surged by 70% YoY but it has decreased by 13% QoQ
Invivyd's equity has decreased by 35% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of IVVD
Market
Shares outstanding
110.11M
Market cap
$466.89M
Enterprise value
$287.63M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$169.56M
EBITDA
-$167.85M
Free cash flow
-$163.15M
Per share
EPS
-$1.55
Free cash flow per share
-$1.49
Book value per share
$2.25
Revenue per share
$0
TBVPS
$2.5
Balance sheet
Total assets
$274.92M
Total liabilities
$28.42M
Debt
$2.57M
Equity
$246.5M
Working capital
$243.31M
Liquidity
Debt to equity
0.01
Current ratio
10.08
Quick ratio
9.89
Net debt/EBITDA
1.07
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-51.2%
Return on equity
-56%
Return on invested capital
-95.8%
Return on capital employed
-68.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IVVD stock price

How has the Invivyd stock price performed over time
Intraday
6%
1 week
37.22%
1 month
1.68%
1 year
214.07%
YTD
7.61%
QTD
7.61%

Financial performance

How have Invivyd's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$166.85M
Net income
-$169.56M
Gross margin
N/A
Net margin
N/A
Invivyd's operating income has increased by 41% YoY and by 2.5% QoQ
The net income has grown by 39% YoY and by 3.2% from the previous quarter

Growth

What is Invivyd's growth rate over time

Valuation

What is Invivyd stock price valuation
P/E
N/A
P/B
1.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IVVD's EPS is up by 3.7% since the previous quarter
Invivyd's equity has decreased by 35% YoY and by 12% from the previous quarter

Efficiency

How efficient is Invivyd business performance
IVVD's return on equity is up by 9% year-on-year but it is down by 7% since the previous quarter
The company's return on assets fell by 8% QoQ but it rose by 4.7% YoY

Dividends

What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IVVD.

Financial health

How did Invivyd financials performed over time
IVVD's total liabilities is down by 40% year-on-year and by 16% since the previous quarter
Invivyd's total assets has decreased by 35% YoY and by 13% from the previous quarter
Invivyd's debt is 99% lower than its equity
Invivyd's debt has surged by 70% YoY but it has decreased by 13% QoQ
Invivyd's equity has decreased by 35% YoY and by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.